Skip to main content Accessibility help
×
Home

Prevention of post-operative nausea and vomiting with combined granisetron and droperidol in women undergoing thyroidectomy

  • Y. Fujii (a1), Y. Saitoh (a2), H. Tanaka (a2) and H. Toyooka (a1)

Abstract

We have compared the efficacy and safety of combined granisetron and droperidol with each anti-emetic alone for preventing post-operative nausea and vomiting after thyroidectomy. In a prospective, randomized, double-blind study, 180 women received granisetron 40 μg kg−1, droperidol 20 μg kg−1, or granisetron 40 μg kg−1 plus droperidol 20 μg kg−1 (n=60 of each) intravenously immediately before induction of anaesthesia. A standard general anaesthetic technique and post-operative analgesia were used. A complete response, defined as no post-operative nausea and vomiting and no need for another rescue anti-emetic, during the first 24 h after anaesthesia occurred in 88%, 60% and 98% of patients who had received granisetron, droperidol and granisetron plus droperidol (P< 0.05; overall Fisher's exact probability test). No clinically important adverse events due to the drugs were observed in any of the groups. In summary, prophylactic use of combined granisetron and droperidol is more effective than each drug alone for the prevention of post-operative nausea and vomiting in female patients undergoing thyroidectomy.

Copyright

Corresponding author

Correspondence: Y. Fujii.

Keywords

Prevention of post-operative nausea and vomiting with combined granisetron and droperidol in women undergoing thyroidectomy

  • Y. Fujii (a1), Y. Saitoh (a2), H. Tanaka (a2) and H. Toyooka (a1)

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed